The evolving landscape of Orally Inhaled and Nasal Drug Product (OINDP) testing makes automation an increasingly attractive option. With the shift towards low global warming potential propellants in Metered Dose Inhalers (MDIs) and an increase in the application of nasal drug delivery, the demand for OINDP testing is higher than ever, and the appeal of improved productivity is clear. However, persistent variability remains a significant challenge, leading to substantial losses in time and resources annually.
This on demand webinar explores the impact of uncontrolled variables on OINDP data integrity and proposes automation as a potential solution. Focus will be drawn to the automation of shaking and firing by the Vertus® III range, and the benefits of controlling parameters such as speed, angle, duration, and force.
Watch the recording here
About the Presenter
Dr Clair Brooks | Applications Specialist
As an accomplished life sciences professional, Clair has extensive experience supporting the start-up and operation of heavily regulated testing labs across both industry and academia. Offering in-depth application support to those working with orally inhaled and nasal drug products (OINDPs) and other pharmaceutical dosage forms, Clair helps analysts ensure regulatory compliant testing and advises on how best to apply Copley products and services to help maximise return on investment.
